"Building Better Pipelines with ADME-Tox," Genetic Engineering & Biotechnology News by Vicki Glaser
Genetic Engineering & Biotechnology News cited Dr. Noel Premkumar, ABC Laboratories' Director of Regulatory Strategy, in a recent article that outlined the growing importance of Phase 0 microdosing studies. With more than 20 years of experience with in-vivo and in-vitro xenobiotic metabolism, Dr. Premkumar's intimate knowledge of Exploratory INDs and Phase 0 studies will equip your development team with information that will enable quick decisions about your molecule.
Click Here to read more!
Note: This file is encrypted with DRM (Digital Rights Management) security control. You will be prompted to
download a .exe file so you can view the PDF.
Please come back soon, presentations will be added shortly.